Fig. 7 | Blood Cancer Journal

Fig. 7

From: Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium

Fig. 7

Contour plot illustrating the joint association of baseline hemoglobin (Hgb) and baseline lactate dehydrogenase (LDH) with median progression-free survival (PFS). Restricted cubic spline models with interaction terms were applied to capture potential non-linear effects. Median PFS (in months) is shown by contour shading, with darker regions representing shorter PFS and lighter regions representing longer PFS.

Back to article page